Gainers
- CounterPath, Corp. (NASDAQ:CPAH) shares jumped 304.1% to close at $3.92 on Friday after the company partnered with Honeywell to create unified communications solution for mobile devices and handheld scanners.
- Origin Agritech Limited (NASDAQ:SEED) gained 46.9% to close at $10.24.
- Sorrento Therapeutics Inc (NASDAQ:SRNE) rose 39.6% to close at $4.76 following news it received an unsolicited acquisition offer from private equity at $7 per share.
- Nektar Therapeutics (NASDAQ:NKTR) gained 24.7% to close at $26.92 after the company and Bristol-Myers agreed to a new joint development plan to advance bempeg plus nivolumab into multiple new registrational trials.
- Monopar Therapeutics Inc. (NASDAQ:MNPR) rose 23.6% to close at $22.00.
- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) shares gained 23.4% to close at $53.96 after the company announced positive topline cohort 3 results and improved longer-term Cohort 2 results from the Phase 1/2 study of DTX301 gene therapy.
- China Green Agriculture, Inc. (NYSE:CGA) rose 23% to close at $3.85.
- PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) shares rose 20.2% to close at $6.79 after the company announced a financing and co-development collaboration with SFJ Pharmaceuticals for PB2452. PhaseBio to receive $120 million in development funding.
- Venus Concept Inc. (NASDAQ:VERO) rose 20% to close at $6.66.
- Caladrius Biosciences, Inc. (NASDAQ:CLBS) climbed 18.8% to close at $3.48.
- Microbot Medical Inc. (NASDAQ:MBOT) surged 18.7% to close at $13.17.
- Revance Therapeutics, Inc. (NASDAQ:RVNC) gained 18.3% to close at $19.50 after the company signed US distribution agreement with TEOXANE SA.
- Aclaris Therapeutics, Inc. (NASDAQ:ACRS) shares rose 17.2% to close at $2.18 after the company announced positive results from ATI-450-PKPD-101.
- OneConnect Financial Technology Co., Ltd. (NYSE:OCFT) climbed 16.8% to close at $15.82.
- ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) gained 16.3% to close at $2.36.
- BioXcel Therapeutics, Inc. (NASDAQ:BTAI) climbed 16.2% to close at $14.24.
- BeyondSpring Inc. (NASDAQ:BYSI) gained 14.7% to close at $18.47.
- La Jolla Pharmaceutical Company (NASDAQ:LJPC) rose 14.3% to close at $6.00.
- Nautilus, Inc. (NYSE:NLS) gained 14.2% to close at $3.22.
- Atomera Incorporated (NASDAQ:ATOM) surged 13.9% to close at $4.17.
- Edesa Biotech, Inc. (NASDAQ:EDSA) gained 13.4% to close at $3.6062.
- SYNNEX Corporation (NYSE:SNX) rose 13% to close at $145.56 after the company reported upbeat results for its fourth quarter and announced plans to separate into two publicly traded companies. The company also issued Q1 earnings guidance above analyst estimates.
- Kala Pharmaceuticals, Inc. (NASDAQ:KALA) surged 12.8% to close at $5.32.
- CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) rose 12.4% to close at $4.99.
- DRDGOLD Limited (NYSE:DRD) surged 10.6% to close at $6.06.
- Calithera Biosciences, Inc. (NASDAQ:CALA) rose 10.6% to close at $6.49.
- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) climbed 10.5% to close at $5.62.
- PolarityTE, Inc. (NASDAQ:PTE) gained 10% to close at $3.31.
- TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) gained 9% to close at $2.90.
- Soleno Therapeutics, Inc. (NASDAQ:SLNO) rose 7% to close at $3.05.
- Beyond Meat, Inc. (NASDAQ:BYND) rose 6.5% to close at $96.07 after climbing 10.76% on Thursday.
- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) rose 6.4% to close at $3.99.
- Simulations Plus, Inc. (NASDAQ:SLP) rose 5.3% to close at $33.37 following strong Q1 results.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Check out these big penny stock gainers and losers
Losers
- Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) shares tumbled 40.3% to close at $14.76 on Friday after the company reported preliminary FY19 Andexxa global net revenues of $111 million.
- RumbleON Inc (NASDAQ:RMBL) fell 26% to close at $0.60 after the company issued Q4 and FY19 sales guidance below analyst estimates, and reported a common stock offering of no disclosed size.
- Inpixon (NASDAQ:INPX) fell 21.4% to close at $4.05 after falling 6.02% on Thursday.
- Six Flags Entertainment Corporation (NYSE:SIX) fell 17.8% to close at $35.96 after the company disclosed that development of co-branded parks in China has encountered continued challenges. Wells Fargo downgraded the stock from Overweight to Equal-Weight and lowered the price target from $49 to $42 per share.
- Sportsman's Warehouse Holdings Inc (NASDAQ:SPWH) fell 16.9% to close at $6.63 after the company lowered its guidance for FY19. The company also issued weak forecast for the fourth quarter.
- Applied Genetic Technologies Corporation (NASDAQ:AGTC) fell 15.4% to close at $7.84 after rising 122.84% on Thursday.
- Kezar Life Sciences, Inc. (NASDAQ:KZR) fell 13.9% to close at $3.29.
- Genetic Technologies Limited (NASDAQ:GENE) dipped 13.1% to close at $4.11.
- Turning Point Therapeutics, Inc. (NASDAQ:TPTX) dipped 13.1% to close at $56.82. Turning Point Therapeutics said Jean Cui will step down as chief scientific officer Jan. 31, with family reasons cited for the departure. Cui, however, will serve as a consultant and support the company during a transition period until June 30.
- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) dropped 11.8% to close at $7.51.
- Aehr Test Systems (NASDAQ:AEHR) fell 10.8% to close at $1.91 after the company reported Q2 results.
- Aptinyx Inc (NASDAQ:APTX) fell 10.7% to close at $3.2150. Aptinyx priced its 10.17 million share common stock offering at $3 per share.
- Flexion Therapeutics, Inc. (NASDAQ:FLXN) dropped 10.5% to close at $18.92.
- Check-Cap Ltd. (NASDAQ:CHEK) tumbled 10.3% to close at $2.01.
- United Natural Foods, Inc. (NYSE:UNFI) shares fell 10.3% to close at $8.48.
- Stage Stores, Inc. (NYSE:SSI) dropped 10% to close at $7.32.
- Monaker Group, Inc. (NASDAQ:MKGI) dipped 9.9% to close at $1.83.
- Atreca, Inc. (NASDAQ:BCEL) dropped 9.7% to close at $14.61.
- Kimbell Royalty Partners, LP (NYSE:KRP) fell 9.3% to close at $15.75 after the company reported a 5 million common unit offering. Kimbell Royalty Partners also reported a $175 Million acquisition of mineral and royalty interests in a cash and unit transaction.
- Pier 1 Imports, Inc. (NYSE:PIR) dropped 6.9% to close at $3.50.
- Chembio Diagnostics, Inc. (NASDAQ:CEMI) dropped 6.6% to close at $4.54 after the company reported the resignation of President and CEO John Sperzel.
- Grubhub Inc. (NYSE:GRUB) fell 6% to close at $52.38. Grubhub said It 'unequivocally' isn't running a sale process, Bloomberg reported.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.